U.S. flag An official website of the United States government
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. Questions and Answers on Informed Consent Elements, 21 CFR § 50.25(c)
  1. Regulatory Information

SMALL ENTITY COMPLIANCE GUIDE

Questions and Answers on Informed Consent Elements, 21 CFR § 50.25(c) Guidance for Sponsors, Investigators, and Institutional Review Boards February 2012

Final
Issued by:
Guidance Issuing Office
Office of Good Clinical Practice
Office of Policy

FDA has prepared this guidance in accordance with section 212 of the Small Business Regulatory Enforcement Fairness Act. It is intended to help small businesses better understand the new informed consent requirements set forth in 21 CFR § 50.25(c).


Submit Comments

Submit comments on this guidance document electronically via docket ID: FDA-2013-S-0610 - Specific Electronic Submissions Intended For FDA's Dockets Management Staff (i.e., Citizen Petitions, Draft Proposed Guidance Documents, Variances, and other administrative record submissions)

If unable to submit comments online, please mail written comments to:

Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

All comments should be identified with the title of the guidance.